Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: A safe and effective adjunctive therapy

Stroke

Volumn 32, Issue 10, 2001, Pages 2328-2332

  Kapadia, Samir R ^a   Bajzer, Christopher T ^a   Ziada, Khaled M ^a   Bhatt, Deepak L ^a   Wazni, Oussama M ^a   Silver, Mitchell J ^a   Beven, Edwin G ^a   Ouriel, Kenneth ^a   Yadav, Jay S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Carotid arteries; Platelets; Stents

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; THIENO[2,3 B]PYRIDINE DERIVATIVE; TICLOPIDINE;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY SURGERY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; STENT; STROKE; SURGICAL RISK;

EID: 0034787984     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs1001.096003     Document Type: Article

References (23)

1. Changes in membrane glycoproteins of circulating platelets after coronary stent implantation
2. Platelet activation and coronary stent implantation: Effect of antithrombotic therapy
3. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement
4. Recognition of the importance of embolization in atherosclerotic vascular disease
5. Role of platelets in restenosis after percutaneous coronary revascularization
6. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
7. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
8. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis
9. Elective stenting of the extracranial carotid arteries
10. Glycoprotein IIb/IIIa receptor inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective
11. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization
12. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomized trial: EPISTENT Investigators: Evaluation of platelet IIb/IIIa inhibitor for stenting
13. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: One-year outcome in the EPILOG trial: Evaluation in PTCA to improve long-term outcome with abciximab GP IIb/IIIa blockade
14. Transcranial Doppler monitoring and causes of stroke from carotid endarterectomy
15. Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography
16. Detection and characterization of emboli during coronary intervention
17. Stenting in the carotid artery: Initial experience in 110 patients
18. Angioplasty and stenting of the extracranial carotid arteries
19. Carotid stenting in patients at risk for surgery: Immediate and long-term results
20. Endovascular stents for carotid artery occlusive disease
21. Stent supported carotid angioplasty (SSCA) in patients with symptomatic coronary artery disease: Acute and long term results
22. Angioplasty and stenting for restenosis after carotid endarterectomy: Initial experience
23. Cervical carotid artery stent placement